微电生理 (688351)
Shanghai MicroPort EP Medtech Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai MicroPort EP MedTech Co., Ltd.
Listing Date2022-08-31
Issue Price16.51RMB
Registered Capital4706010k RMB
Legal RepresentativeSun Yiyong
Registered AddressBuilding 28, No. 1-28, Lane 588, Tianxiong Road, Zhoupu Town, Pudong New Area, Shanghai
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of innovative medical devices in the field of electrophysiology interventional diagnosis and therapy as well as ablation treatment.
Company ProfileShanghai MicroPort EP MedTech Co., Ltd. is a high-tech enterprise focused on the research, development, production, and sales of innovative medical devices in the field of electrophysiology interventional diagnosis and therapy as well as ablation treatment. It is committed to providing globally competitive 'integrated diagnostic and ablation therapy solutions centered on precise interventional navigation'. After over a decade of continuous innovation, in the field of cardiac electrophysiology, the company is one of the few manufacturers in the global market that has completed a comprehensive layout of both cardiac electrophysiology equipment and consumables. It is also the first domestic manufacturer capable of providing a complete solution for 3D cardiac electrophysiology equipment and consumables, having overcome many key technologies in this field and broken the long-term technological monopoly of foreign manufacturers.
The company holds 22 NMPA medical device registration certificates and filing certificates, 4 EU CE registration certificates, and multiple other overseas product registration certificates. The '3D Cardiac Electrophysiology Mapping System' was selected for the 2018 National Innovative Medical Device Product Catalog and the 2018-2019 Shanghai Biomedical Innovation Product List. The 'Magnetic Positioning Adjustable Curve Mapping Catheter' was selected for the 2018-2019 Shanghai Biomedical Innovation Product List.
Stock Details
1. Key Indicators
- Total Shares(W): No relevant data
- Circulating A-Shares(W): No relevant data
- Earnings Per Share(RMB): No relevant data
- Net Assets Per Share(RMB): No relevant data
- Operating Revenue(W RMB): No relevant data
- Total Profit(W RMB): No relevant data
- **Net Profit Attributable to Parent(W RMB) **: No relevant data
- Net Profit Growth Rate(%): No relevant data
- Weighted Return on Equity(%): No relevant data
- Operating Cash Flow Per Share(RMB): No relevant data
- Undistributed Profit Per Share(RMB): No relevant data
- Capital Reserve Per Share(RMB): No relevant data
2. Main Business
The main business covers:
- No relevant data
3. Company Basic Information
- Company Name: No relevant data
- Listing Date: No relevant data
- Industry: No relevant data
- Address: No relevant data
- Website: No relevant data
- Company Profile: No relevant data
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | ChinaAMC Innovative Healthcare Theme Hybrid Securities Investment Fund Class A | Fund | 472.84 | 3.79 |
| 2 | ChinaAMC Medical Services Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 426.09 | 3.41 |
| 3 | Huabao CSI Medical ETF | Fund | 403.74 | 3.23 |
| 4 | ChinaAMC Daxin Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 311.68 | 2.50 |
| 5 | Shanghai Zhangjiang Torch Venture Capital Co., Ltd. | General Legal Person | 250.00 | 2.00 |
| 6 | ChinaAMC Healthcare Hybrid Securities Investment Fund | Fund | 191.02 | 1.53 |
| 7 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 187.01 | 1.50 |
| 8 | China Life Insurance Company Limited - Dividend - Individual Dividend - 005L-FH002 Shanghai | Insurance | 134.17 | 1.07 |
| 9 | Changsheng Pension Health Industry Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 31.92 | 0.26 |
| 10 | BXR Fullgoal Healthy Living Theme Flexible Allocation Hybrid Securities Investment Fund | Fund | 20.00 | 0.16 |
5. Concept Sectors
- Margin Trading
- Increased Margin Financing
- New Insurance Holdings
- Fund Reduction
- Specialized, Refined, Special and New
- SSE Innovation
- STAR Market Biotech
- STAR 200
- SSE 580
Remarks
- Data update date: 2025-09-30
- Data source: Public market information